Wegovy (semaglutide 2.4 mg) is also approved for weight management in adolescents aged 12 years and older with obesity (BMI 95th percentile for age and sex)
All medications come from licensed 503A compounding pharmacies and are HSA/FSA eligible across all 50 states
Obesity-induced dysregulation of skin-resident Ppar(+) Treg cells promotes Il-17a-mediated psoriatic inflammation
Cost & Accessibility Both medications are expensive , averaging $900$1,200 per month in the U.S., depending on insurance coverage, manufacturer savings programs, or compounding access
In addition, HFD also promotes apoptotic processes at the hypothalamic level 62 , and weight-lowering therapies, as exercise, contribute to mitigate apoptosis in hypothalamic neurons 60
Bacteriostatic (BAC) Water: This is the industry standard for reconstitution